Nurix Therapeutics Inc
Research Nurix Therapeutics Inc (NRIX) on Bullrun: market cap USD 2.79B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNRIX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.79B
- Financial periodQ2 2026
- RevenueUSD 9.04M
- Net income-USD 89.54M
- Free cash flow-USD 98.51M
Valuation Snapshot
latest market cap is USD 2.79B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 83.98M | -USD 264.46M | -USD 263.47M | n/a | -3.05 | USD 246.96M | USD 55.73M | USD 538.75M |
| FY2024 | USD 54.55M | -USD 193.57M | -USD 181.86M | n/a | -2.88 | USD 110.00M | USD 28.30M | USD 526.99M |
| FY2023 | USD 76.99M | -USD 143.95M | -USD 89.77M | n/a | -2.65 | USD 54.63M | USD 30.61M | USD 200.49M |
| FY2022 | USD 38.63M | -USD 180.36M | -USD 172.05M | n/a | -3.71 | USD 64.47M | USD 14.51M | USD 303.70M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.79B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.93B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.43B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 502.78M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 517.95M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.29B | n/a | n/a | n/a |
About Nurix Therapeutics Inc
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nurix Therapeutics Inc's market cap?
Nurix Therapeutics Inc's market capitalization is USD 2.79B.
What does Nurix Therapeutics Inc do?
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.